Introduction

Acrodysostosis is a rare condition that affects bone development, leading to features like very short fingers and toes, unusual facial structure, and a small nose. In the past,  diagnosing acrodysostosis was sometimes confusing because it can be mistaken for other similar conditions like Albright hereditary osteodystrophy (AHO), which includes forms such as pseudohypoparathyroidism type 1a (PHP1a) or pseudopseudohypoparathyroidism (PPHP). Another uncertainty was whether people with acrodysostosis had issues with mineral metabolism and resistance to certain hormones, similar to PHP1a. Recent research has helped clarify these issues, improving our understanding of acrodysostosis.^2,3

Recently, scientists discovered that mutations affecting a specific gene (PRKAR1A) are linked to classic acrodysostosis and issues with hormone response. This breakthrough allows doctors to categorize these disorders based on their genetic causes.¹ The patients with acrodysostosis have been found to have genetic defects in one of two specific genes: PRKAR1A or PDE4D. These genes are involved in the signaling pathway that includes the proteins GPCR, Gsα, cAMP, and protein kinase A (PKA). Thanks to these discoveries, genetic testing can now accurately diagnose most cases of acrodysostosis. These proteins play critical roles in various tissues,  so the condition presents differently in different people, including whether they experience hormonal resistance. There are now two identified forms of acrodysostosis: ADOHR, caused by PRKAR1A defects, and ADOP4, caused by PDE4D defects. Hormonal resistance is a key feature of ADOHR but not of ADOP4.^3,4

Clinical features

Patients with acrodysostosis show specific bone and facial abnormalities. These include a broad face, widely spaced eyes, and a small nose. Their hands and feet have short, stubby fingers and toes, except for enlarged big toes. Adults with acrodysostosis are usually very short in height.

Acrodysostosis involves several bone-related abnormalities that can be identified through X-rays. On radiographs, patients typically have a small skull with thickened bones at the top of their head (calvaria). The bones in their hands and feet are affected symmetrically, showing severe shortening (brachydactyly type E) with cone-shaped ends that fuse early at the joints. This results in limited movement in the fingers and toes.⁵

Many patients also have bones that appear older than their actual age during childhood or adolescence. Some patients may have more severe shortening of specific fingers or toes than others. For example, a few individuals with acrodysostosis might have shorter fourth and fifth fingers or third to fifth toes severely affected than other digits. However, all fingers and toes are generally affected in some way.⁶ 

In many patients, there is also a reduction in the normal widening between the bones in the lower back (lumbar interpedicular distance, the distance between the pedicles of the lumbar vertebrae.  

Although similarities exist between patients with ADOHR and ADOP4, there are differences, too. For ADOP4 patients, the small nose and facial features could be more severe, including a flattened nasal bridge. In one instance, a patient initially diagnosed with acroscyphodysplasia was later identified to have ADOP4. Most ADOHR patients are born smaller than expected for their gestational age, which isn't typically seen in ADOP4 patients. Interestingly, some ADOP4 patients may not have a notably short stature at all.^6,7

Symptoms and management

Acrodysostosis is a rare condition occurring from birth that comes with distinct physical traits. One of the symptoms is spinal stenosis- the spinal canal is narrower than usual from a young age, which can lead to serious problems later on.⁸ This is because of the narrowing pressure on the spinal cord, which is crucial for sending signals between the brain and the rest of the body. In some cases, this pressure can lead to symptoms like numbness or weakness in the limbs, difficulty walking, or even problems with bladder or bowel control.⁹

Early detection of spinal stenosis in acrodysostosis is essential. If detected early, surgery can often relieve the pressure on the spinal cord, allowing for a better chance of recovery and avoiding long-term nerve damage.9 Regular check-ups and awareness of potential symptoms are crucial for managing this aspect of the condition effectively.

In addition, people with acrodysostosis often have shorter, misshapen fingers and toes due to having shorter bones. They may also have a flattened nasal bridge and, sometimes, learning difficulties. 

In acrodysostosis, individuals may be at an increased risk of developing deep vein thrombosis (DVT) due to their unique skeletal and vascular features. The hallmark symptoms of DVT include swelling, redness, warmth, and pain in the affected leg. The underlying cause of DVT in acrodysostosis may be related to impaired blood flow due to bone abnormalities affecting circulation or other yet unknown factors associated with the syndrome. Neurological symptoms such as neuropathic pain and spasticity (muscle stiffness) can also occur.¹⁰

Symptoms may also include distinct facial features such as a small nose and often being born small for gestational age (SGA). Children with these types of acrodysostosis tend to have advanced bone age and experience a noticeable decline in height percentile before puberty, resulting in severe short stature in adulthood. Treatment with recombinant human growth hormone (rhGH) has shown some promise in improving height outcomes, especially when started early. It helps mitigate the height decline observed before puberty and may prevent further loss of height during adolescence. However, its effectiveness varies among individuals, highlighting the need for personalized treatment approaches. 

The patients with iPPSD4 may also experience hormonal resistance, affecting the body’s response to hormones like parathyroid hormone (PTH) and thyroid-stimulating hormone (TSH), whereas this is less common in iPPSD5. Some individuals with iPPSD5 may develop early-onset obesity, contrasting with a generally normal BMI in iPPSD4.¹¹

Overall, managing acrodysostosis involves addressing its skeletal abnormalities, monitoring growth closely, and considering rhGH therapy in appropriate cases to optimize height outcomes.

Differentiating acrodysostosis from similar conditions: key features

Acrodysostosis can sometimes resemble conditions like pseudohypoparathyroidism (PHP) and pseudopseudohypoparathyroidism (PPHP), due to their similarities in bone and facial features. However, there are key differences that can help doctors distinguish them. 

Acrodysostosis is characterised by specific bone abnormalities, a small nose (pug nose), and sometimes mental retardation, without the hormonal imbalances seen in pseudohypoparathyroidism. In contrast, pseudohypoparathyroidism involves metabolic issues like abnormal calcium levels, whereas pseudopseudohypoparathyroidism shows hormonal abnormalities in tests, like cyclic adenosine monophosphate (cAMP) levels. To diagnose acrodysostosis correctly, doctors look for these unique physical traits and may perform genetic tests to confirm. This helps differentiate it from similar conditions based solely on symptoms and imaging results.¹²

How does acrodysostosis affect daily life?

• Physical appearance: The differences in bone growth can make the hands and feet look different from those of other people. The small nose can also be a noticeable feature.
• Learning difficulties: Children with acrodysostosis might need special educational support to help them learn and develop skills at their own pace.
• Hearing support: Many individuals with acrodysostosis will need assistance with hearing, such as using hearing aids or learning sign language.

Summary

Acrodysostosis is a rare genetic condition affecting bone development, characterised by short fingers and toes, distinctive facial features like a small nose, and sometimes learning difficulties. Recent research identified two types based on genetic mutations: ADOHR, linked to PRKAR1A gene defects causing hormone resistance, and ADOP4, linked to PDE4D mutations. Both types share skeletal abnormalities but differ in the severity of affected facial features and short stature.

People with acrodysostosis are prone to spinal stenosis, where the spinal canal narrows and can compress the spinal cord, leading to symptoms like limb weakness or numbness. They also face a heightened risk of DVT due to vascular issues related to bone abnormalities. Early detection of spinal stenosis is crucial for timely surgical intervention, which alleviates pressure on the spinal cord and prevents long-term nerve damage. Regular check-ups are essential for managing these aspects of the condition effectively.

Hormone resistance related to GPCR signaling is a characteristic feature specific to ADOHR. These findings not only clarify the underlying causes of these diseases but also emphasize the roles of PRKAR1A and PDE4D in cAMP signaling across different tissues, particularly in the GPCR-Gsα-cAMP-PKA pathway, which is crucial for cognitive function development. Further research, both in laboratory settings and in living organisms, is needed to explore the functional implications of PDE4D mutations. Additionally, understanding how similar skin pigmentation issues arise in genetic disorders involving both the inhibition and activation of the PKA pathway remains an intriguing area for investigation. Importantly, while PRKAR1A and PDE4D mutations are implicated in most cases, there is still a possibility that other genetic defects may also contribute to acrodysostosis, with or without hormonal resistance.